A phase II study of vorinostat (MK-0683) in patients with primary myelofibrosis and post-polycythemia vera myelofibrosis

被引：21
|
作者：
Andersen, Christen L. [1 ]
Mortensen, Nana B. [1 ]
Klausen, Tobias W. [2 ]
Vestergaard, Hanne [3 ]
Bjerrum, Ole W. [4 ]
Hasselbalch, Hans C. [1 ]
机构：
[1] Roskilde Univ Hosp, Dept Hematol, Roskilde, Denmark
[2] Herlev Univ Hosp, Dept Hematol, DK-2730 Herlev, Denmark
[3] Odense Univ Hosp, Dept Hematol, DK-5000 Odense, Denmark
[4] Copenhagen Univ Hosp, Rigshosp, Dept Hematol, Copenhagen, Denmark
来源：
HAEMATOLOGICA | 2014年 / 99卷 / 01期
关键词：
primary myelofibrosis; post-polycythemia vera; vorinostat; monotherapy; clinical response; INTERNATIONAL-WORKING-GROUP; ESSENTIAL THROMBOCYTHEMIA; DEACETYLASE INHIBITOR; MYELOID METAPLASIA; CRITERIA; PANOBINOSTAT; DIAGNOSIS; TRIAL;
D O I：
10.3324/haematol.2013.096669
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] A PHASE II STUDY OF VORINOSTAT (MK-0683) IN PATIENTS WITH PRIMARY MYELOFIBROSIS (PMF) AND POST-POLYCYTHAEMIA VERA MYELOFIBROSIS (PPV-MF)
    Andersen, C.
    Mortensen, N.
    Vestergaard, H.
    Bjerrum, O.
    Klausen, T.
    Hasselbalch, H.
    HAEMATOLOGICA, 2013, 98 : 120 - 120
  • [2] A Phase II Study of Vorinostat (MK-0683) in Patients with Polycythemia Vera and Essential Thrombocythemia
    Andersen, Christen Lykkegaard
    McMullin, Mary Frances
    Ejerblad, Elisabeth
    Zweegman, Sonja
    Harrison, Claire N.
    Fernandes, Savio
    Bareford, David
    Knapper, Steven
    Samuelsson, Jan
    Lofvenberg, Eva
    Linder, Olle
    Andreasson, Bjorn
    Ahlstrand, Erik
    Jensen, Morten K.
    Bjerrum, Ole Weis
    Vestergaard, Hanne
    Larsen, Herdis
    Klausen, Tobias Wirenfeldt
    Mourits-Andersen, Torben
    Hasselbalch, Hans
    BLOOD, 2012, 120 (21)
  • [3] Phase II Study of Sunitinib in Patients With Primary or Post-Polycythemia Vera/Essential Thrombocythemia Myelofibrosis
    Apostolidou, Effrosyni
    Kantarjian, Hagop
    Thomas, Deborah
    Burger, Ian
    Borthakur, Gautam
    Verstovsek, Srdan
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2010, 10 (04): : 281 - 284
  • [4] A phase II study of vorinostat (MK-0683) in patients with polycythaemia vera and essential thrombocythaemia
    Andersen, Christen L.
    McMullin, Mary F.
    Ejerblad, Elisabeth
    Zweegman, Sonja
    Harrison, Claire
    Fernandes, Savio
    Bareford, David
    Knapper, Steven
    Samuelsson, Jan
    Loefvenberg, Eva
    Linder, Olle
    Andreasson, Bjorn
    Ahlstrand, Erik
    Jensen, Morten K.
    Bjerrum, Ole W.
    Vestergaard, Hanne
    Larsen, Herdis
    Klausen, Tobias W.
    Mourits-Andersen, Torben
    Hasselbalch, Hans C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 162 (04) : 498 - 508
  • [5] A phase II study of panobinostat in patients with primary myelofibrosis (PMF) and post-polycythemia vera/essential thrombocythemia myelofibrosis (post-PV/ET MF)
    Mascarenhas, John
    Sandy, Lonette
    Lu, Min
    Yoon, James
    Petersen, Bruce
    Zhang, David
    Ye, Fei
    Newsom, Carrie
    Najfeld, Vesna
    Hochman, Tsivia
    Goldberg, Judith D.
    Hoffman, Ronald
    LEUKEMIA RESEARCH, 2017, 53 : 13 - 19
  • [6] Oxidative stress is increased in primary and post-polycythemia vera myelofibrosis
    Vener, Claudia
    Novembrino, Critina
    Catena, Fabrizia Bamonti
    Fracchiolla, Nicola Stefano
    Gianelli, Umberto
    Savi, Federica
    Radaelli, Franca
    Fermo, Elisa
    Cortelezzi, Agostino
    Lonati, Silvia
    Menegatti, Marzia
    Deliliers, Giorgio Lambertenghi
    EXPERIMENTAL HEMATOLOGY, 2010, 38 (11) : 1058 - 1065
  • [7] A phase II trial of tipifarnib in myelofibrosis: primary, post-polycythemia vera and post-essential thrombocythemia
    Mesa, R. A.
    Camoriano, J. K.
    Geyer, S. M.
    Wu, W.
    Kaufmann, S. H.
    Rivera, C. E.
    Erlichman, C.
    Wright, J.
    Pardanani, A.
    Lasho, T.
    Finke, C.
    Li, C. Y.
    Tefferi, A.
    LEUKEMIA, 2007, 21 (09) : 1964 - 1970
  • [8] A phase II trial of tipifarnib in myelofibrosis: primary, post-polycythemia vera and post-essential thrombocythemia
    R A Mesa
    J K Camoriano
    S M Geyer
    W Wu
    S H Kaufmann
    C E Rivera
    C Erlichman
    J Wright
    A Pardanani
    T Lasho
    C Finke
    C Y Li
    A Tefferi
    Leukemia, 2007, 21 : 1964 - 1970
  • [9] Cutaneous involvement by post-polycythemia vera myelofibrosis
    Pecci, Alessandro
    Croci, Giorgio
    Balduini, Carlo L.
    Boveri, Emanuela
    AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (04) : 448 - 448
  • [10] The Evolving Understanding of Prognosis in Post-Essential Thrombocythemia Myelofibrosis and Post-Polycythemia Vera Myelofibrosis vs Primary Myelofibrosis
    Masarova, Lucia
    Verstovsek, Srdan
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (05) : 299 - 307
12345